Log In
BCIQ
Print this Print this
 

ITI-012

  Manage Alerts
Collapse Summary General Information
Company Intra-Cellular Therapies Inc.
DescriptionCasein kinase 1 (CSNK1; CKI) inhibitor
Molecular Target Casein kinase 1 (CSNK1) (CKI)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today